On September 5, 2023 IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, reported its participation in upcoming investor relations events (Press release, Ideaya Biosciences, SEP 5, 2023, View Source [SID1234634919]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Citi 18th Annual BioPharma Conference
Wednesday, September 6th, 2023 at 1:00 PM ET
Targeted Oncology Panel participation by Paul Stone, Chief Financial Officer, hosted by Yigal D. Nochomovitz, Ph.D., Director, SMid Cap Biotech Analyst.
Morgan Stanley 21st Annual Global Healthcare Conference
Monday, September 11th, 2023 at 10:40 AM ET
Fireside chat with Yujiro S. Hata, Chief Executive Officer, hosted by Ryuk Byun, MD, Executive Director.
A live audio webcast of conference events, as permitted by conference host, will be available at the "Investors/News and Events/Investor Calendar" section of the IDEAYA website at View Source and/or through the conference host. A replay of available webcasts will be accessible for 30 days following the live event.